Open AccessShould implementation of new health technology in low- and middle-income countries follow the same guidelines as multinational drug trials?
Author(s) -
Jean Pierre Niyitegeka,
Riana Patel
Publication year - 2020
Publication title -
bulletin of the royal college of surgeons of england
Language(s) - English
Resource type - Journals
eISSN - 1478-7075
pISSN - 1473-6357
DOI - 10.1308/rcsbull.2020.117
Subject(s) - multinational corporation , low and middle income countries , drug trial , drug , business , medicine , clinical trial , economic growth , developing country , economics , pharmacology , finance , pathology
One size fits all isn’t always the case.